FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Stefan Buchholz

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Procedures

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Ferenc Rick; Andrew V Schally; Stephan Seitz; Andreas Stadlmayr; Luca Szalontay; Norman L Block; Stefan Buchholz; Christian Datz; AWTAR KRISHAN; Florian Hohla
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
Ferenc Rick; Andrew V Schally; Stephan Seitz; Andreas Stadlmayr; Luca Szalontay; Elmar Aigner; Norman Block; Stefan Buchholz; Christian Datz; AWTAR KRISHAN; Roberto Perez; Florian Hohla
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Ferenc Rick; Andrew V Schally; Luca Szalontay; Karoly Szepeshazi; Marta Zarandi; Norman Block; Stefan Buchholz; Florian Hohla; Mehrdad Nadji; Stephan Seitz
Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Stefan Buchholz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2012: Ferenc Rick; Andrew V Schally; Stephan Seitz; Andreas Stadlmayr; Luca Szalontay; Norman L Block; Stefan Buchholz; Christian Datz; AWTAR KRISHAN; Florian Hohla
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
Cell cycle (Georgetown, Tex.) 2012;11(22):4203-10.
2012: Ferenc Rick; Andrew V Schally; Stephan Seitz; Andreas Stadlmayr; Luca Szalontay; Elmar Aigner; Norman Block; Stefan Buchholz; Christian Datz; AWTAR KRISHAN; Roberto Perez; Florian Hohla
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Cell cycle (Georgetown, Tex.) 2012;11(13):2518-25.
2012: Ferenc Rick; Andrew V Schally; Luca Szalontay; Karoly Szepeshazi; Marta Zarandi; Norman Block; Stefan Buchholz; Florian Hohla; Mehrdad Nadji; Stephan Seitz
Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(5):1655-60.
2008: Elmar Heinrich; Andrew V Schally; Stefan Buchholz; Ferenc Rick; Gabor Halmos; Melinda Mile; Kate Groot; Florian Hohla; Marta Zarandi; Jozsef Varga
Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
The Prostate 2008;68(16):1763-72.
2007: Florian Hohla; Andrew V Schally; Celia A Kanashiro; Stefan Buchholz; Ben Baker; Chandrika Kannadka; Angelika Moder; Elmar Aigner; Christian Datz; Gabor Halmos
Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(47):18671-6.
2007: Stefan Buchholz; Andrew V Schally; Jörg Engel; Florian Hohla; Elmar Heinrich; Frank Koester; Jozsef Varga; Gabor Halmos
Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(6):1943-6.
2006: Florian Hohla; Andrew V Schally; Karoly Szepeshazi; Jozsef Varga; Stefan Buchholz; Frank Köster; Elmar Heinrich; Gabor Halmos; Ferenc Rick; Chandrika Kannadka; Christian Datz; Celia A Kanashiro
Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(39):14513-8.
2006: Stefan Buchholz; Gunhild Keller; Andrew V Schally; Gabor Halmos; Florian Hohla; Elmar Heinrich; Frank Koester; Ben Baker; Jörg Engel
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(27):10403-7.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.